Medpace names new executive vice president of operations

Medpace Holdings, Inc. has appointed Brad W. Hansman, age 43, as Executive Vice President, Operations effective June 1, 2026.

Rhea-AI Filing Summary

Medpace Holdings, Inc. has appointed Brad W. Hansman, age 43, as Executive Vice President, Operations effective June 1, 2026. In this role he will perform the functions of principal operating officer alongside existing Executive Vice President, Operations, Susan E. Burwig.

Hansman has been with Medpace since 2011, progressing through finance and key operational leadership roles overseeing study start-up, logistics, regulatory affairs, and medical writing. Earlier in his career he worked at Joseph Decosimo & Company and Macy’s and holds a BBA in Accounting and is a Certified Public Accountant (inactive).

In connection with the new role, Hansman will receive an annual base salary of $492,250, be eligible for the company’s short-term cash bonus plan based on a percentage of salary, and may receive awards under the long-term equity incentive plan at the Compensation Committee’s discretion. He has entered into Medpace’s standard indemnification agreement for executive officers.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Annual base salary: $492,250 Effective date of appointment: June 1, 2026 Executive age: 43 years

3 metrics

Annual base salary $492,250 Executive Vice President, Operations compensation

Effective date of appointment June 1, 2026 Start date as Executive Vice President, Operations

Executive age 43 years Age of Brad W. Hansman at appointment

Key Terms

Executive Vice President, Operations, principal operating officer, short-term incentive compensation plan, long-term equity incentive plan, +1 more

5 terms

Executive Vice President, Operations financial

"appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations"

principal operating officer financial

"shall perform the functions of the Company’s principal operating officer along with Susan E. Burwig"

short-term incentive compensation plan financial

"eligible to participate in the short-term incentive compensation plan providing target cash bonus opportunities"

long-term equity incentive plan financial

"and the Company’s long-term equity incentive plan at the discretion of the Compensation Committee"

indemnification agreement financial

"entered into the Company’s standard indemnification agreement for directors and executive officers"

An indemnification agreement is a contract in which one party promises to cover losses, costs, or legal claims that another party might face, acting like a tailored safety net or private insurance policy. For investors, it matters because such agreements shift potential financial risk away from a company or its officers and onto the indemnifier, which can affect a company’s future liabilities, cash flow and how risky the investment appears during deal-making or litigation.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive leadership change did Medpace (MEDP) announce on June 1, 2026?

Medpace appointed Brad W. Hansman as Executive Vice President, Operations, effective June 1, 2026. He will share principal operating officer responsibilities with existing EVP Susan E. Burwig, strengthening operational leadership across study start-up, logistics, regulatory affairs, and medical writing functions within the organization.

What is Brad Hansman’s compensation in his new Medpace (MEDP) role?

Brad Hansman will receive an annual base salary of $492,250 as Executive Vice President, Operations. He will also be eligible for a short-term cash bonus based on a percentage of salary and potential long-term equity incentives at the Compensation Committee’s discretion.

What experience does Brad Hansman bring to his new Medpace (MEDP) position?

Brad Hansman has been with Medpace since 2011, moving from Finance & Accounting into key operational leadership roles. He previously worked at Joseph Decosimo & Company as an audit supervisor and at Macy’s in auditor positions, and holds a BBA in Accounting and CPA (inactive) credentials.

Does Brad Hansman have any related-party or conflict-of-interest ties at Medpace (MEDP)?

Medpace states Brad Hansman has no family relationships with current directors, nominees, or executive officers. The company also notes no transactions in which he has a material interest requiring disclosure under Item 404(a) of Regulation S-K, reducing potential conflict-of-interest concerns.

Will Brad Hansman receive equity as part of his Medpace (MEDP) compensation?

Brad Hansman will be eligible to participate in Medpace’s long-term equity incentive plan at the discretion of the Board’s Compensation Committee. Any future equity awards would complement his base salary and cash bonus opportunity, aligning part of his pay with long-term company performance.

What legal protections did Medpace (MEDP) grant Brad Hansman as an executive officer?

Brad Hansman entered into Medpace’s standard indemnification agreement for directors and executive officers. This agreement typically provides certain protections against personal liability arising from his official duties, subject to applicable law and the company’s charter and bylaws.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 04:06 PM Learn about SEC filing dates

false 0001668397 0001668397 2026-06-01 2026-06-01

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 1, 2026

MEDPACE HOLDINGS, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware		001-37856		32-0434904
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

5375 Medpace Way

Cincinnati, Ohio 45227

(Address of Principal Executive Offices, and Zip Code)

(513) 579-9911

Registrant’s Telephone Number, Including Area Code

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock $0.01 par value		MEDP		Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective June 1, 2026, Medpace Holdings, Inc. (the “Company”) appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations. In this role, Mr. Hansman shall perform the functions of the Company’s principal operating officer along with Susan E. Burwig, the Company’s Executive Vice President, Operations.

Mr. Hansman joined the Company in April 2011 in Finance & Accounting and held various roles in Finance until July 2015. Since August 2015, Mr. Hansman has held various key leadership roles in operations including Executive Director, Vice President, and Senior Vice President overseeing study start-up, logistics, regulatory affairs, and medical writing. Prior to joining the Company, Mr. Hansman worked for Joseph Decosimo & Company, LLC as an Audit Supervisor from July 2008 to March 2011. Mr. Hansman started his career at Macy’s, Inc. where he held various auditor positions from July 2006 to June 2008. Mr. Hansman received his Bachelor of Business Administration in Accounting from Eastern Kentucky University and is a Certified Public Accountant (inactive). Mr. Hansman does not hold any public company directorships.

Mr. Hansman has no family relationships with any current director, director nominee, or executive officer of the Company, and there are no transactions or proposed transactions, to which the Company is a party, or intended to be a party, in which he has, or will have, a material interest subject to disclosure under Item 404(a) of Regulation S-K. Mr. Hansman was not appointed as the Company’s Executive Vice President, Operations, pursuant to any arrangement or understanding with any other person.

In connection with his appointment, Mr. Hansman will receive an annual base salary of $492,250 and will be eligible to participate in the short-term incentive compensation plan providing target cash bonus opportunities (expressed as a percentage of base salary and as described in the Company’s Proxy Statement filed with the Securities and Exchange Commission on April 1, 2026) and the Company’s long-term equity incentive plan at the discretion of the Compensation Committee of the Board of Directors of the Company.

Mr. Hansman and the Company have entered into the Company’s standard indemnification agreement for directors and executive officers.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				MEDPACE HOLDINGS, INC.
Date: June 4, 2026				By:		/s/ Stephen P. Ewald
				Name:		Stephen P. Ewald
				Title:		General Counsel and Corporate Secretary

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.1 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 16.8 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 10.5 KB